Bigfoot Biomedical today announced an agreement with Pittsburgh-based Allegheny Health Network (AHN) to further develop Bigfoot’s Unity investigational insulin delivery wireless platform. The diabetes startup described Unity as a first-in-kind data-driven solution for optimizing insulin dosing and delivery. Bigfoot will work alongside AHN endocrinologists and primary care doctors to refine Unity’s clinical workflow features. Get the full […]
50 medtech startups you need to know
Medical device industry accelerator MedTech Innovator today announced about 50 medtech startups participating in its annual four-month program. Half are early-stage companies participating in MedTech Innovator’s Accelerator and Showcase program, and the other half are mid-stage companies in the organization’s Showcase program. The list of companies is a who’s who of people around the world […]
Bigfoot Biomedical, Owen Mumford ink deal for pen needles
Bigfoot Biomedical said today that it inked a commercial supply deal to include Owen Mumford‘s Pentips line of pen needles with Bigfoot’s injection system subscription bundles. Milpitas, Calif.-based Bigfoot is working on monthly subscription packages for people with insulin-requiring diabetes. The company said it selected Owen Mumford’s pen needle because of the needle’s compatibility with all disposable […]
Bigfoot Biomedical inks insulin deal with Eli Lilly
Bigfoot Biomedical said today that it inked a non-exclusive deal with Eli Lilly (NYSE:LLY) to integrate Eli Lilly’s insulin products into Bigfoot’s investigational insulin delivery devices. The California-based company expects to launch its first two insulin delivery systems – Bigfoot Inject and Bigfoot Loop – in 2020, contingent upon finishing a pivotal trial and landing regulatory approvals. Get […]
NuVasive taps Medtronic surgical innovation prez Barry as new CEO | Personnel Moves – October 19, 2018
NuVasive (NSDQ:NUVA) said today it named Medtronic (NYSE:MDT) surgical innovations prez J. Barry as its new CEO, replacing Gregory Lucier, effective November 5. Barry will also join the company’s board of directors, where Lucier will continue to serve as board chair and aid in transition efforts, the San Diego-based company said. NuVasive also said that it promoted current strategy, […]
Speakers you need to see at DeviceTalks Minnesota
A Google executive whose own heart problems spurred her to seek medtech innovation, a leader at Abbott who wants to drive healthcare value, the head of an upstart company seeking to transform diabetes care — those are but some of the speakers you will encounter at DeviceTalks Minnesota this June. Read on to find out […]
How Bigfoot Biomedical’s CEO wants to boost diabetes management
Jeffrey Brewer faced the biggest challenge of his life when his 7-year-old son Sean received a diabetes diagnosis in 2002: Diabetes became the new focus for Brewer’s energy. In his role as CEO at JDRF (formerly the Juvenile Diabetes Research Foundation) between 2011 and 2014, Brewer forged financial partnerships with industry to drive the development […]
Bigfoot brings Series B total to $55m with new investment from Abbott
Reeling in an $18 million add-on to the $37 million Series B that it reported last year, Bigfoot Biomedical touted today that it has raised over $90 million in total funding since the Milpitas, Calif.-based company first launched. Investments from Abbott (NYSE:ABT), which has an established partnership with Bigfoot, and other new and existing investors, brought the Series B round total […]
7 top stories that mattered for medtech in 2017
The medtech industry saw its transformation accelerate in 2017: Whether it’s the roster of largest companies, business models or the regulatory environment, times are a-changing. Competition is also heating up in areas including diabetes care and robotic surgery. Here are seven stories that mattered for the medical device industry this year. Next>>
Bigfoot Biomedical raises $37m in Series B
Bigfoot Biomedical said today that it has raised $37 million in the first tranche of a Series B round, co-led by foot doctor rancho cucamonga ca and the company’s largest existing investor, Quadrant Capital Advisors. The Milpitas, Calif.-based company plans to use its newly-acquired funds to support product development and clinical evaluation of its automated insulin […]
DeviceTalks West: Here are the speakers you’ll see
Hundreds of medical device industry insiders are expected to descend on Orange County, Calif., this month for DeviceTalks West – a premier boutique networking and learning event. From the VP in charge of Medtronic’s neurovascular business to the artificial pancreas pioneer Jeffrey Brewer, here are some of the speakers you’ll meet at DeviceTalks West, Dec. 11–12 […]
MassDevice Network
@MassDevice
LinkedIn
YouTube